Item 3 of the Schedule 13D is hereby amended and supplemented by adding the following disclosure to Item 3: As previously disclosed, on May 18, 2026, Critical Metals Corp. ("Critical Metals" or the "Company") entered into a binding Scheme Implementation Deed with European Lithium Ltd. (ASX: EUR) ("European Lithium" or the "Reporting Person"), as amended and restated from time to time (the "Scheme Implementation Deed"), under which Critical Metals agreed to acquire all of the issued shares and listed options of European Lithium by way of two interdependent schemes of arrangement under Part 5.1 of the Australian Corporations Act 2001 (Cth), comprising a scheme between European Lithium and its shareholders (the "Share Scheme") and a scheme between European Lithium and the holders of its listed options (the "Option Scheme" and, together with the Share Scheme, the "Schemes" and the transactions contemplated thereby, the "Transaction"). Following the approval of the Schemes by European Lithium's shareholders and option holders on October 22, 2026, the Supreme Court of Western Australia (the "Court") made orders approving the Schemes on October 26, 2026. The Schemes became effective on October 27, 2026 upon lodgment of an office copy of the Court orders with the Australian Securities and Investments Commission. On November 5, 2026 (the "Implementation Date"), Critical Metals completed the Transaction and European Lithium became a wholly owned subsidiary of Critical Metals. On the Implementation Date, Critical Metals issued an aggregate of 90,539,994 ordinary shares of Critical Metals ("Ordinary Shares"), of which (i) 78,414,558 Ordinary Shares were issued as consideration under the Share Scheme, based on a transaction ratio of 0.045 Ordinary Shares for each European Lithium share, (ii) 7,989,037 Ordinary Shares were issued as consideration under the Option Scheme, and (iii) 4,136,399 Ordinary Shares were issued to certain holders of unlisted options and Class 1 and Class 2 performance rights of European Lithium. As a result of the Transaction, European Lithium became a wholly owned subsidiary of Critical Metals. Following the Transaction, European Lithium continues to hold the 45,536,338 Ordinary Shares that it acquired in February 2024, however all rights attaching to such Ordinary Shares, including voting and dividend rights, are suspended under the Company's amended and restated memorandum and articles of association, as described below under "Amendments to Memorandum and Articles of Association." Immediately following the Transaction, including as a result of the suspension of rights held by European Lithium described above, there were 194,219,631 Ordinary Shares issued and outstanding. The Ordinary Shares held by European Lithium described above, which contain no voting and dividend rights, will be accounted for by Critical Metals as treasury shares. In addition, upon the occurrence of the Implementation Date, (i) Amendment No. 4, dated September 28, 2026, to the Agreement and Plan of Merger, dated as of October 24, 2022, by and between Critical Metals and European Lithium, as previously amended, became effective, which terminates Critical Metals' obligation to issue up to 6,778,838 Ordinary Shares to European Lithium as earnout consideration thereunder, and (ii) the Termination Agreement, dated September 28, 2026, by and between Critical Metals and European Lithium became effective, which terminates the Investors Agreement, dated as of February 27, 2024, by and between Critical Metals and European Lithium.

Item 4 of the Schedule 13D is hereby amended to incorporate the amendments set forth in Item 3 to this Amendment No. 8 to Item 4.

Item 5 of the Schedule 13D is hereby amended to incorporate the amendments set forth in Item 3 to this Amendment No.8 to Item 5 and Items 5(a) - (e) of the Schedule 13D.

Item 5 of the Schedule 13D is hereby amended to incorporate the amendments set forth in Item 3 to this Amendment No.8 to Item 5 and Items 5(a) - (e) of the Schedule 13D.

Item 5 of the Schedule 13D is hereby amended to incorporate the amendments set forth in Item 3 to this Amendment No.8 to Item 5 and Items 5(a) - (e) of the Schedule 13D.

Item 5 of the Schedule 13D is hereby amended to incorporate the amendments set forth in Item 3 to this Amendment No.8 to Item 5 and Items 5(a) - (e) of the Schedule 13D.

Item 5 of the Schedule 13D is hereby amended to incorporate the amendments set forth in Item 3 to this Amendment No.8 to Item 5 and Items 5(a) - (e) of the Schedule 13D.

Item 6 of the Schedule 13D is hereby amended to incorporate the amendments set forth in Item 3 to this Amendment No. 8 to Item 6.

Exhibit No. Description 99.9 Amended and Restated Memorandum and Articles of Association of Critical Metals Corp. (Stage 2), registered with the Registrar of Corporate Affairs in the British Virgin Islands on November 5, 2026. (incorporated by reference to Exhibit 99.3 to the Report on Form 6-K of Critical Metals Corp., filed with the SEC on November 5, 2026). 99.10 Amendment No. 4 to Agreement and Plan of Merger, dated as of September 28, 2026, by and between Critical Metals Corp. and European Lithium Ltd. (incorporated by reference to Exhibit 99.1 to the Report on Form 6-K of Critical Metals Corp., filed with the SEC on October 2, 2026). 99.11 Termination Agreement, dated as of September 28, 2026, by and between Critical Metals Corp. and European Lithium Ltd., terminating the Investors Agreement dated as of February 27, 2024 (incorporated by reference to Exhibit 99.2 to the Report on Form 6-K of Critical Metals Corp., filed with the SEC on October 2, 2026).